Key Takeaways:
- Ginkgo Bioworks and Invaio Sciences have announced a collaboration to develop microbial strains for large-scale production of peptide-based crop protection inputs.
- The partnership focuses on optimizing industrial fermentation processes to support commercialization.
- Invaio is advancing peptide-based solutions to address pest resistance to conventional chemistry.
- Ginkgo will apply its strain engineering platform and automated lab infrastructure to meet production targets.
- The collaboration aims to deliver scalable, cost-effective manufacturing aligned with grower needs.
Ginkgo to Support Industrial-Scale Peptide Production
Ginkgo Bioworks (NYSE: DNA) has entered into a collaboration with Invaio Sciences, an agricultural biotechnology company focused on nature-positive crop protection solutions. The partnership is designed to develop microbial strains capable of efficiently manufacturing peptide-based crop protection products at industrial scale.
As growers face increasing pest resistance to conventional chemical inputs, alternative solutions are being explored. Invaio’s platform focuses on discovering and developing peptide-based crop protection technologies intended to complement or offer alternatives to traditional chemistries, while meeting standards for efficacy, affordability, and ease of adoption.
Strain Engineering and Fermentation Optimization
Under the agreement, Ginkgo will leverage its microbial engineering platform and protein production strains to support Invaio’s commercialization efforts. The strains are engineered to serve as optimized starting points for protein and peptide production through industrial-scale fermentation.
9 Comments